Berlin - Delayed Quote EUR

Editas Medicine Inc (8EM.BE)

1.4525
-0.1110
(-7.10%)
As of 8:01:25 AM GMT+2. Market Open.
Loading Chart for 8EM.BE
  • Previous Close 1.5635
  • Open 1.4525
  • Bid 1.5710 x --
  • Ask 1.6150 x --
  • Day's Range 1.4525 - 1.4525
  • 52 Week Range 0.8166 - 5.4160
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8EM.BE

View More

Performance Overview: 8EM.BE

Trailing total returns as of 6/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8EM.BE
25.27%
S&P 500 (^GSPC)
0.51%

1-Year Return

8EM.BE
68.24%
S&P 500 (^GSPC)
12.02%

3-Year Return

8EM.BE
85.75%
S&P 500 (^GSPC)
41.54%

5-Year Return

8EM.BE
94.07%
S&P 500 (^GSPC)
91.89%

Compare To: 8EM.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8EM.BE

View More

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    126.93M

  • Enterprise Value

    -39.93M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.10

  • Price/Book (mrq)

    2.39

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8EM.BE

View More

Company Insights: 8EM.BE

Research Reports: 8EM.BE

View More